Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2b study of M110101 in seborrheic dermatitis
jRCT2080221910Phase 2
- Sponsor
- Maruho Co., Ltd.
- Start
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in seborrheic dermatitis (SD) comparing M110101 active treatment with M110101 placebo (2 arms).
02
Drugs
03
Conditions
seborrheic dermatitis (SD)
Beyond the preview
Go deeper on jRCT2080221910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221910.